DK536677A - 5-(substitueret phenyl)-oxazolidinoner og deres svovlanaloge samt fremgangsmaade til fremstilling heraf - Google Patents
5-(substitueret phenyl)-oxazolidinoner og deres svovlanaloge samt fremgangsmaade til fremstilling herafInfo
- Publication number
- DK536677A DK536677A DK536677A DK536677A DK536677A DK 536677 A DK536677 A DK 536677A DK 536677 A DK536677 A DK 536677A DK 536677 A DK536677 A DK 536677A DK 536677 A DK536677 A DK 536677A
- Authority
- DK
- Denmark
- Prior art keywords
- oxazolidinones
- procedure
- preparation
- substituted phenyl
- sulfur analog
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/16—Sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2655369 | 1976-12-03 | ||
| DE19762655369 DE2655369A1 (de) | 1976-12-03 | 1976-12-03 | 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung |
| DE2745320 | 1977-10-05 | ||
| DE19772745320 DE2745320A1 (de) | 1977-10-05 | 1977-10-05 | 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung ii |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK536677A true DK536677A (da) | 1978-06-04 |
| DK149850B DK149850B (da) | 1986-10-13 |
| DK149850C DK149850C (da) | 1987-04-27 |
Family
ID=25771221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK536677A DK149850C (da) | 1976-12-03 | 1977-12-02 | Analogifremgangsmaade til fremstilling af 5-(3,4-disubst. phenyl)-oxazolidinoner eller thiazolidinoner eller de tilsvarende thioner |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5382777A (da) |
| AT (1) | AT357529B (da) |
| AU (1) | AU519994B2 (da) |
| CA (1) | CA1097657A (da) |
| CH (1) | CH635578A5 (da) |
| CS (1) | CS199694B2 (da) |
| DD (1) | DD133667A5 (da) |
| DK (1) | DK149850C (da) |
| FR (1) | FR2372814A1 (da) |
| GB (1) | GB1588639A (da) |
| GR (1) | GR64964B (da) |
| HU (1) | HU175676B (da) |
| IE (1) | IE46435B1 (da) |
| IL (1) | IL53520A (da) |
| IT (1) | IT1089341B (da) |
| LU (1) | LU78616A1 (da) |
| NL (1) | NL7713153A (da) |
| SE (1) | SE441446B (da) |
| SU (1) | SU888821A3 (da) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2701215C2 (de) * | 1977-01-13 | 1982-10-14 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Thiazolin-2-thionen |
| US4348393A (en) * | 1978-06-09 | 1982-09-07 | Delalande S.A. | N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones |
| DE3438839A1 (de) * | 1984-10-19 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | Pharmazeutische praeparate |
| WO1987006576A1 (en) * | 1986-04-29 | 1987-11-05 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
| US5459145A (en) * | 1988-01-19 | 1995-10-17 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
| JPH01135098U (da) * | 1988-03-11 | 1989-09-14 | ||
| WO1991007177A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| US5461056A (en) * | 1992-05-08 | 1995-10-24 | Pfizer Inc. | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| GB9212673D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
| GB9222253D0 (en) * | 1992-10-23 | 1992-12-09 | Celltech Ltd | Chemical compounds |
| GB9226830D0 (en) * | 1992-12-23 | 1993-02-17 | Celltech Ltd | Chemical compounds |
| US5622977A (en) * | 1992-12-23 | 1997-04-22 | Celltech Therapeutics Limited | Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same |
| GB9304920D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| GB9326173D0 (en) * | 1993-12-22 | 1994-02-23 | Celltech Ltd | Chemical compounds and process |
| ATE260911T1 (de) * | 1993-12-22 | 2004-03-15 | Celltech R&D Ltd | Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe |
| US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
| US6245774B1 (en) | 1994-06-21 | 2001-06-12 | Celltech Therapeutics Limited | Tri-substituted phenyl or pyridine derivatives |
| GB9412573D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9412571D0 (en) | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9412672D0 (en) * | 1994-06-23 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9526246D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9526245D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9608435D0 (en) * | 1996-04-24 | 1996-06-26 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9619284D0 (en) * | 1996-09-16 | 1996-10-30 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9622363D0 (en) * | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9625184D0 (en) * | 1996-12-04 | 1997-01-22 | Celltech Therapeutics Ltd | Chemical compounds |
| AU5330698A (en) * | 1996-12-23 | 1998-07-17 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| GB9705361D0 (en) | 1997-03-14 | 1997-04-30 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9924862D0 (en) | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
-
1977
- 1977-11-28 SU SU772546252A patent/SU888821A3/ru active
- 1977-11-29 NL NL7713153A patent/NL7713153A/xx not_active Application Discontinuation
- 1977-12-01 LU LU78616A patent/LU78616A1/xx unknown
- 1977-12-01 SE SE7713635A patent/SE441446B/xx not_active IP Right Cessation
- 1977-12-01 DD DD7700202354A patent/DD133667A5/xx unknown
- 1977-12-01 IT IT30254/77A patent/IT1089341B/it active
- 1977-12-02 CH CH1477977A patent/CH635578A5/de not_active IP Right Cessation
- 1977-12-02 IL IL53520A patent/IL53520A/xx unknown
- 1977-12-02 DK DK536677A patent/DK149850C/da not_active IP Right Cessation
- 1977-12-02 HU HU77SCHE632A patent/HU175676B/hu not_active IP Right Cessation
- 1977-12-02 JP JP14492277A patent/JPS5382777A/ja active Granted
- 1977-12-02 CA CA292,273A patent/CA1097657A/en not_active Expired
- 1977-12-02 IE IE2446/77A patent/IE46435B1/en not_active IP Right Cessation
- 1977-12-02 AU AU31175/77A patent/AU519994B2/en not_active Expired
- 1977-12-02 GB GB50350/77A patent/GB1588639A/en not_active Expired
- 1977-12-02 GR GR54913A patent/GR64964B/el unknown
- 1977-12-05 AT AT868677A patent/AT357529B/de not_active IP Right Cessation
- 1977-12-05 FR FR7736525A patent/FR2372814A1/fr active Granted
- 1977-12-05 CS CS778086A patent/CS199694B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IT1089341B (it) | 1985-06-18 |
| SU888821A3 (ru) | 1981-12-07 |
| FR2372814A1 (fr) | 1978-06-30 |
| AT357529B (de) | 1980-07-10 |
| GR64964B (en) | 1980-06-10 |
| IE46435B1 (en) | 1983-06-15 |
| DK149850B (da) | 1986-10-13 |
| SE441446B (sv) | 1985-10-07 |
| IE772446L (en) | 1978-06-03 |
| NL7713153A (nl) | 1978-06-06 |
| AU519994B2 (en) | 1982-01-07 |
| GB1588639A (en) | 1981-04-29 |
| FR2372814B1 (da) | 1980-10-10 |
| AU3117577A (en) | 1979-06-07 |
| DD133667A5 (de) | 1979-01-17 |
| CS199694B2 (en) | 1980-07-31 |
| JPS6154792B2 (da) | 1986-11-25 |
| JPS5382777A (en) | 1978-07-21 |
| IL53520A (en) | 1981-07-31 |
| LU78616A1 (da) | 1978-04-20 |
| IL53520A0 (en) | 1978-03-10 |
| CH635578A5 (en) | 1983-04-15 |
| DK149850C (da) | 1987-04-27 |
| SE7713635L (sv) | 1978-06-04 |
| ATA868677A (de) | 1979-12-15 |
| CA1097657A (en) | 1981-03-17 |
| HU175676B (hu) | 1980-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK536677A (da) | 5-(substitueret phenyl)-oxazolidinoner og deres svovlanaloge samt fremgangsmaade til fremstilling heraf | |
| DK47476A (da) | Benzoylureido-diphenylethere samt fremgangsmade til deres fremstilling og anvendelse | |
| DK470277A (da) | Liprosomer indeholdende heparin og fremgangsmaade til deres fremstilling | |
| FR2461870B1 (fr) | Vanne regulatrice | |
| DK528979A (da) | Silicageler fremgangsmaade til deres fremstilling samt deres anvendelse | |
| DK47376A (da) | Benzoylureido-nitro-diphenylethere samt fremgangsmade til deres fremstilling og anvendelse | |
| DK357677A (da) | Bererfikserede enzymer samt fremgangsmade til fremstilling og anvendelse heraf | |
| DK540678A (da) | Polypeptider samt fremgangsmaade til fremstilling heraf | |
| DK194377A (da) | Pyrrolidoner samt deres fremstilling og anvendelse | |
| DK21079A (da) | Substituerede heterocycloske benzamider samt fremgangsmaade til fremstilling deraf | |
| DK358678A (da) | 1,4-bis-amino-anthraquinonforbindelser samt deres anvendelse og fremstilling | |
| DK407577A (da) | Azabicycloforbindelser samt deres fremstilling og anvendelse | |
| SE7803700L (sv) | Rele | |
| DK388377A (da) | Cephalosporiner samt fremgangsmaade til fremstilling deraf | |
| DK184679A (da) | Substituerede 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepiner fremgangsmaade til deres fremstilling samt deres anvendelse | |
| DK244275A (da) | 3-(4-aminopiperazin-1-yl-alkyl)-indol-forbindelser samt fremgangsmade til deres fremstilling og anvendelse | |
| DK461179A (da) | Fremgangsmaade til fremstilling af azolylketaler og deres anvendelse som mikrobicider | |
| DK375180A (da) | Moertler ud fra uorgansike bindemidler fremgangsmaade til fremstilling deraf samt deres anvendelse | |
| DK38778A (da) | Azacycloalkaner azacycloalkener og derivater deraf samt fremgangsmaade til fremstilling deraf | |
| DK206377A (da) | Substituerede pyrazolopyriminer fremgangsmade til deres fremstilling samt deres anvendelse | |
| DK29876A (da) | Svovlholdige octapeptidderivater samt fremgangsmade til fremstilling heraf | |
| DK402877A (da) | 1-amino-2-hydroxy-3-heterocyclyloxy-propansalte deraf samt fremgangsmaade til fremstilling deraf | |
| DK279777A (da) | Carbostyriler samt deres fremstilling og anvendelse | |
| DK279877A (da) | 1-acyloxy-1-phenyl-2-azolyl-ethaner fremgangsmade til deres fremstilling samt deres anvendelse som fungicider og nematodicicider | |
| DK72979A (da) | Phenylnitraminer med fungcid virkning samt deres fremstilling og anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |